Polybio
-
Research updates, September 29
A small clinical trial found Remdesivir was safe for people with Long COVID and that some exploratory results warrant a larger trial. The U.K. trial, which included 73 participants who took a five day course of the intravenous antiviral COVID-19 drug, was published in Oxford Open Immunology.
-
VIPER aims to fast track Long COVID biomarkers. Here’s how it works.
Led by researchers at UCSF, the research program plans to validate promising candidates for noninvasive tests that can be used to advance clinical trials.
-
PolyBio’s Spring 2026 symposium: Advancing Long COVID biomarkers and treatments
The PolyBio Research Foundation recently announced new initiatives and centered biomarkers during their latest virtual conference.
-
Live blog: PolyBio’s Fall 2025 Symposium shares Long COVID and related disease research updates
Leading Long COVID and related disease researchers are set to present updates to their work today at the PolyBio Research Foundation’s Fall 2025 Symposium. PolyBio supports some of the most highly-anticipated research projects in infection-associated chronic conditions (IACCs).
-
Live blog: Following the Spring 2025 PolyBio Symposium on Long COVID and related diseases
Leading scientists studying Long COVID and related chronic diseases are set to present updates to their work on Friday at the PolyBio Research Foundation’s Spring Symposium. The Sick Times’ team will be following the presentations throughout the day.
-
Finding an accepted Long COVID biomarker will be complicated. This blood test could give us answers.
Last year, immunologist Johan Van Weyenbergh published a study in The Lancet: Microbe that identified a potential blood-based biomarker for Long COVID with 94% sensitivity. Van Weyenbergh’s team discovered SARS-CoV-2 RNA transcripts in the blood cells of people with Long COVID. They also found a specific type of RNA, called ORF1ab RNA, which suggested there…
-
Live blog: Following the Fall 2024 PolyBio Symposium on Long COVID research
On Friday, a number of prominent Long COVID scientists are set to present updates on their work at the PolyBio Research Foundation’s fall research symposium. PolyBio is a leading organization in supporting formative Long COVID science; it has backed research into Long COVID’s biological causes as well as clinical trials aiming to address those underlying…
-
PolyBio announces $15 million in Long Covid research funding, new projects studying viral persistence
PolyBio Research Foundation, a leading organization in supporting research for Long Covid and related chronic diseases, announced a new round of funding focused on identifying potential Long Covid treatments on Thursday. The research projects, which received a total of $15 million in funding, plan to study the potential biological underpinnings of Long Covid and begin…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
Trans people with Long COVID navigate a new “dark age” in trans health
-
National COVID-19 trends, October 13
-
Research updates, October 13
-
How I built a COVID-safer school that’s become the heart of a more caring community
-
Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance